Biomedicines MDPI’s Post

📝 Therapeutic Potential of EVs: Targeting Cardiovascular Diseases — Francés, et al. In this paper, the authors aimed to discuss the up-to-date knowledge regarding the biophysical properties and biological components of EVs, focusing on myocardial infarction, diabetic cardiomyopathy, and sepsis-induced cardiomyopathy, three very different types of CVDs. Full text is available 👇 https://lnkd.in/dHuP5FyR #medicine #health #research #science 

#HighlyCitedPapers 📝Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression — Ou et al. In this paper, the authors aimed to examine whether the urinary Gal-3 level is also a useful biomarker enabling the accurate prediction of the risk of #kidney disease progression. Full text is available 👇 https://lnkd.in/dM_HJsZN #medicine #health #research #science

Precision Medicine: A Beacon of Hope for Rare Diseases! Precision medicine is revolutionizing the treatment of rare diseases by tailoring therapies to individual genetic profiles. This personalized approach enhances accuracy, improves outcomes, and offers new hope for patients. Discover how this cutting-edge field is transforming healthcare! 🧬💊 #PrecisionMedicine #RareDiseases #PersonalizedHealthcare

#PaperoftheDay: "Study of the role of leukocyte telomere length-related lncRNA NBR2 in Alzheimer’s disease" DOI ⬇️ https://lnkd.in/e2EMKMGy #aging #alzheimers #research #openaccess #peerreview #publishing

As a chronic progressive inflammatory disease, atherosclerosis constitutes a leading cause of cardiovascular disease, with high mortality and morbidity worldwide. In this study, the authors aimed to explore the regulatory mechanism of the lncRNA AC078850.1/HIF-1α complex in #atherosclerosis. 📝 Long Noncoding RNA AC078850.1 Induces NLRP3 Inflammasome-Mediated Pyroptosis in Atherosclerosis by Upregulating ITGB2 Transcription via Transcription Factor HIF-1α — Tian, et al. Full text is available 👇 https://lnkd.in/d_2u8Ctb #medicine #health #research #science 

#HighlyCitedPapers   📝 The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives — Papadopoulos, et al.   In this paper, the authors discuss the established interconnections between the gut microbiota and cardiovascular disease, as well as the plausible therapeutic perspectives.   Full text is available 👇 https://lnkd.in/d2itNGfv   #medicine #health #research #science

🚨🔬The latest publication from the NECESSITY consortium sheds light on Sjögren’s disease, a condition known for its heterogeneity and lack of clear classification for the variety of symptoms observed in Sjögren’s patients. Using cluster analysis based on subjective symptoms, clinical, and biological manifestations, the study identified 3 distinct subgroups. In total 26 variables were used to cluster the population into these subgroups, to also allow for a comparative analysis of the prognosis between the three. The #findings suggest that the three subgroups represent different heterogeneous #pathophysiological disease mechanisms, stages of disease, or both. These #subgroups can be used further for the #stratification of patients in future #therapeutic trials! Read more about this groundbreaking research in our latest publication, with special thanks to Yann Nguyen, Pr Raphaèle Seror (MD, PhD), Gaetane Nocturne, PhD, Fai Ng for their efforts on this study! Our article link: https://lnkd.in/edmEgcrv #SjögrensDisease #NECESSITYConsortium #ResearchPublication #MedicalScience

Thrilled to share that our latest research study ”Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based study" is now published in RMD open, BMJ. We studied the risk of developing cardiac arrhythmia and its subtypes over time in all patients with systemic sclerosis (SSc) in Sweden, and explored potential risk factors for arrhythmia and whether arrhythmia is associated with mortality. Special thanks to my amazing supervisor and co-authors. The full article: https://lnkd.in/dPZj6w_f #rheumatology #scleroderma

Looking to advance your research in inflammatory bowel disease (IBD) and colitis models? MP Biomedicals' #Dextran Sodium Sulphate (DSS) is your go-to solution, trusted by researchers worldwide for its consistent performance and reliability in inducing colitis in experimental animals. Why Choose MP Biomedicals' DSS? ✅ High Purity & Quality: Ensures reproducible results across your studies. ✅ Proven in Research: Widely used in inflammation and #gastrointestinalresearch models. ✅ Global Trust: Backed by scientists and research labs worldwide. Whether you're studying IBD, #guthealth, or inflammatory mechanisms, our #DSS is here to support your breakthrough discoveries! Click to learn more https://zurl.co/bSYr #InnovateWithDSS 

Did you know you are able to search for a clinical research study and filter the results based on your diagnosis, stage of kidney disease, and whether or not you have proteinuria? Head on over to Renal Disease Research Institute's page to check out this useful feature! We must continue finding ways to connect patients and their doctors with scientifically feasible and ethical research studies. This new approach is one way we hope to improve and simplify this process. https://lnkd.in/dP26XMCD